基于免疫细胞谱的成人起病Still病内型:层次聚类分析的患者分层
本研究纳入95例未治疗成人起病Still病(AOSD)患者和66例健康对照,基于循环免疫细胞进行无偏层次聚类分析,将AOSD分为三个内型组。第3组(CD8优势组)诊断时全身评分最高、更易出现肺部浸润、心包炎、脾大且治疗反应较差,随访24.6(15.2)个月期间疾病复发总数最高。
要点
- AOSD患者中性粒细胞和CD8+ T细胞比例显著升高,单核细胞、自然杀伤细胞和CD4+ T细胞降低(均P < 0.005)。
- 层次聚类将95例AOSD分为中性粒细胞优势组、单核细胞优势组和CD8+ T细胞优势组三个内型。
- CD8优势组诊断时全身评分最高、更易有肺部浸润、心包炎、脾大且治疗反应较差,随访期间复发总数最高(P < 0.0001)。
核心结论
- 外周免疫细胞层次聚类分析将AOSD分为三个疾病相关内型,第3组表现为更高的全身评分和更差的治疗反应。
研究设计与样本
- 纳入95例未治疗AOSD患者和66例健康对照,基于循环免疫细胞进行无偏层次聚类分析,分析临床和实验室特征、治疗管理、全身评分及结局。
主要发现
- AOSD患者中性粒细胞和CD8+ T细胞比例显著高于健康对照,单核细胞、自然杀伤细胞和CD4+ T细胞降低(均P < 0.005)。
- 层次聚类将95例AOSD分为三组:第1组中性粒细胞百分比最高(中性粒细胞优势组),第2组单核细胞百分比最高(单核细胞优势组),第3组CD8+ T细胞百分比最高(CD8优势组)。
- 第3组诊断时全身评分最高,更易出现肺部浸润、心包炎、脾大和较差的治疗反应。
- CD4与CD8比值与全身评分呈负相关(P = 0.001),与治疗反应呈正相关(P = 0.0091)。
- 随访24.6(15.2)个月期间,第3组疾病复发总数最高(P < 0.0001)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: This study aimed to analyse the immune cell profiles of adult-onset Still's disease (AOSD) and to stratify disease-associated endotypes. METHODS: We included 95 cases of treatment-naïve patients with AOSD and 66 cases of healthy controls. Patients with AOSD were classified via an unbiased hierarchical cluster analysis based on circulating immune cells. Their clinical and laboratory characteristics, treatment management, systemic scores and outcomes were then analysed. RESULTS: The proportions of neutrophils and CD8+ T cells were significantly higher while monocytes and natural killer and CD4+ T cells were decreased in patients with AOSD (all P < 0.005). Unbiased hierarchical cluster analysis classified 95 AOSD into three endotype-based groups: group 1 had the highest percentage of neutrophils (neu-dominant group), group 2 had the highest percentage of monocytes (mono-dominant group) and group 3 had the highest percentage of CD8+ T cells (CD8-dominant group). Patients in group 3 had the highest systemic score at diagnosis and were more likely to have pulmonary infiltrates, pericarditis, splenomegaly and poorer treatment responses. A correlation study revealed that the CD4 to CD8 ratio was negatively correlated with the systemic score and positively correlated with treatment response in patients with AOSD (P = 0.001 and P = 0.0091). During the 24.6 (15.2) months of follow-up, the highest total number of disease flares occurred in group 3 (P < 0.0001). CONCLUSION: Hierarchical cluster analysis of peripheral immune cells classified AOSD into three disease-related endotypes. Group 3 showed higher systemic score and poorer treatment responses.
引用
- Guo R, Liu X, Li Y, et al. AOSD endotypes based on immune cell profiles: patient stratification with hierarchical clustering analysis. Rheumatology (Oxford). 2023. PMID: 35972374. doi:10.1093/rheumatology/keac439
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。